7 05, 2015 Corrado Iaccarino et al., Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy. Clinical Neurology and Neurosurgery Diatech Pharmacogenetics2017-08-08T11:43:22+02:00 Leggi di più